STREAMLINE HEALTH SOLUTIONS INC. - Common Stock, $0.01 par value (STRM)

Historical Holders from Q1 2014 to Q3 2025

Symbol
STRM on Nasdaq
Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
4,279,000
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-1
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of STREAMLINE HEALTH SOLUTIONS INC. - Common Stock, $0.01 par value (STRM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Tamarack Advisers, LP 3.6% $35,430 154,044 Ferayorni Justin John 13 Nov 2024

Institutional Holders of STREAMLINE HEALTH SOLUTIONS INC. - Common Stock, $0.01 par value (STRM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 0 $0 -$1,038,000 0
2025 Q2 200,000 $1,038,000 +$1,038,000 $5.19 1
2025 Q1 0 $0 -$230 0
2024 Q4 1,000 $230 -$2,015,431 $0.23 1
2024 Q3 8,760,612 $2,015,639 -$1,722,095 $0.2301 23
2024 Q2 12,386,588 $5,719,610 +$25,132 $0.4608 29
2024 Q1 5,041,358 $2,420,226 -$179,380 $0.48 11
2023 Q4 17,730,542 $7,555,537 -$341,474 $0.425 38
2023 Q3 17,883,693 $17,266,568 -$1,226,514 $0.9675 43
2023 Q2 19,143,429 $24,292,810 +$128,567 $1.27 39
2023 Q1 18,942,356 $34,066,810 +$1,804,857 $1.8 37
2022 Q4 17,905,435 $28,280,607 +$2,552,327 $1.58 35
2022 Q3 16,375,130 $19,466,900 +$5,714,770 $1.19 29
2022 Q2 11,568,957 $14,685,700 -$202,808 $1.27 24
2022 Q1 11,702,066 $18,722,000 -$7,236,972 $1.6 26
2021 Q4 16,597,901 $24,685,000 -$1,330,157 $1.47 25
2021 Q3 17,411,227 $30,465,500 -$1,748,740 $1.75 29
2021 Q2 18,406,782 $32,568,700 -$1,260,442 $1.77 32
2021 Q1 18,962,602 $38,835,500 +$11,453,695 $2.05 33
2020 Q4 14,050,823 $22,134,600 +$423,058 $1.56 28
2020 Q3 13,865,990 $21,632,600 +$202,001 $1.56 27
2020 Q2 13,293,639 $17,681,566 +$591,698 $1.33 24
2020 Q1 13,055,175 $11,094,670 -$1,104,248 $0.8497 26
2019 Q4 14,133,488 $19,646,178 +$7,210,940 $1.39 26
2019 Q3 8,944,416 $9,713,220 +$185,729 $1.08 26
2019 Q2 8,795,828 $13,385,402 -$54,626 $1.51 26
2019 Q1 8,838,356 $9,279,710 -$61,146 $1.05 26
2018 Q4 8,979,356 $7,234,825 -$253,482 $0.8081 30
2018 Q3 7,398,077 $8,773,036 -$116,393 $1.18 31
2018 Q2 7,522,393 $10,738,994 -$72,831 $1.41 28
2018 Q1 7,603,017 $13,973,368 +$700,784 $1.84 28
2017 Q4 7,195,641 $12,132,000 -$8,300 $1.69 32
2017 Q3 7,139,413 $10,494,000 -$454,063 $1.47 22
2017 Q2 7,509,089 $8,034,000 -$1,564,838 $1.07 24
2017 Q1 9,110,700 $9,291,000 +$297,755 $1.02 32
2016 Q4 9,159,696 $11,431,000 +$336,390 $1.25 34
2016 Q3 9,028,164 $16,567,000 +$855,566 $1.84 38
2016 Q2 8,538,778 $10,246,000 -$1,184,463 $1.2 32
2016 Q1 9,191,902 $12,961,000 -$384,605 $1.41 34
2015 Q4 9,568,204 $13,484,000 -$3,720,318 $1.41 33
2015 Q3 11,091,123 $25,398,000 -$367,852 $2.29 37
2015 Q2 11,167,849 $31,267,892 -$479,240 $2.8 35
2015 Q1 11,272,829 $40,082,000 -$1,116,409 $3.55 33
2014 Q4 11,261,126 $48,748,211 -$507,493 $4.33 39
2014 Q3 11,076,842 $51,283,000 -$202,098 $4.63 39
2014 Q2 11,092,105 $53,507,000 +$3,797,890 $4.8 40
2014 Q1 10,342,660 $52,027,000 +$847,202 $5.03 39